Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung-Reference-Cited by-同舟云学术

Konjunktivales Mantelzelllymphom – eine therapeutische Herausforderung

Published:2021-07-28 Issue: Volume: Page:
ISSN:0941-293X
Container-title:Der Ophthalmologe
language:de
Short-container-title:Ophthalmologe

Author:

Trouvain André M.,Bocqué Catheline,Müller Lisa J.,Heinrich Christoph,Bewarder Moritz,Pérez Guerra Núria,Szurman Gesine,Becker Sören L.,Rickmann Annekatrin^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s00347-021-01462-w.pdf

Reference21 articles.

1. Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D’Amore F, Nilsson-Ehle H, Jensen P, Pedersen M, Geisler CH, Jerkeman M (2014) Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study. Blood 124(8):1288–1295. https://doi.org/10.1182/blood-2014-03-559930

2. Amstutz CA, Michel S, Thiel MA (2004) Follicular conjunctivitis caused by a mantle cell lymphoma. Klin Monbl Augenheilkd 221(5):398–400. https://doi.org/10.1055/s-2004-812865

3. Auw-Hädrich C, Reinhard T (2019) Konjunktivale Malignome. Ophthalmologe 116(10):989–1004. https://doi.org/10.1007/s00347-019-00978-6

4. Ferrer A, Salaverria I, Bosch F, Villamor N, Rozman M, Beà S, Giné E, López-Guillermo A, Campo E, Montserrat E (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 109(12):2473–2480. https://doi.org/10.1002/cncr.22715

5. Hermine O, Hoster E, Walewski J et al (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet 388(10044):565–575. https://doi.org/10.1016/S0140-6736(16)00739-X